Skip to content

Public FDA record

Z-1468-2014: CODMAN CERTAS Programmable Valves, central nervous system shunt, models as follows: 82-8800 In Line Val

Recall record Z-1468-2014 for Codman & Shurtleff, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1468-2014
Company in FDA record
Codman & Shurtleff, Inc.
FDA classification date
Apr 17, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Ensuring all customers have the tools to assist in verifying the setting of the valve on x-ray images and the location and orientation of implanted CODMAN CERTAS Programmable Valves.

Source facts

Action
Codman Neuro issued notification packages dated 12/13/13 to Domestic Hospitals and international accounts. Specific letters and associated inclusion of the additional aids, include A) a valve setting verification guide with instructions for use with x-ray images, and B) a plastic valve cut out overlay). A response reply form was included to be completed and returned to confirm effectiveness of the notification.
Initiated
2013-12-13
Root cause
Process control
Terminated
2016-04-21
Distribution
Nationwide Distribution.
Recall number
Z-1468-2014
Recall status
Terminated
CDRH record ID
126333
FDA classified
2014-04-17
Recall event number
67793

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗